Virtu Pharmako
Hangzhou
About Virtu Pharmako
Virtu Pharmako is a Sino-foreign joint venture biopharmaceutical business focused on the manufacturing of biosimilars, novel biological pharmaceuticals, and biological products represented by insulin and GLP-1 receptor agonists.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $35.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: virtupharmako.com
- Phone: 573-83229366
Industries & Categories
Biotechnology, Medical
Canonical: https://fsome.com/organization/virtu-pharmako-98283 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.